GDF15 and hydrops fetalis: Chronic increase in circulating GDF15 levels have been reported both in HFpEF and HFrEF patients [187], and GDF15 has recently emerged as a strong and independent biomarker for identifying patients displaying HF with midrange or preserved EF with a worse prognosis [192].